The rise of AI and synthetic biology has made deadly diseases look like a ‘low-risk, high-reward’ option for would-be ...

What determines how long we live—and to what extent is our lifespan shaped by our genes? Surprisingly, for decades, scientists believed that the heritability of human lifespan was relatively low ...

By looking at how sci-fi movies used emergent technologies to discuss pressing issues, we get a clearer picture of the 1990s ...

From Frank's RedHot to Hellmann's, AI already changed what we taste, but greater success in test kitchens will be harder for artificial intelligence to create.

On March 25, 2026 the Jeffrey Modell Foundation (JMF) will host Donald B. Kohn, MD, a Distinguished Professor at the ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...

From rare cancers caught early to dementia foretold decades in advance, newborn genomic testing raises an unsettling question ...

A new AI model by Google DeepMind can decipher DNA and predict mutations, opening new doors for disease research. View on euronews ...

The purpose of this survey was to combine qualitative and quantitative insights to understand the current oncology landscape.

Oliver van Veen, the chief executive officer (CEO) of Vannin Healthcare, says the federal government should adopt a ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...